Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.
  • If my paper is accepted - I agree to pay any article processing fees associated with this paper.
    The article-processing charge of MCT is $1000/ £770/€870 for each article accepted for publication. The charges can be waived or discounted on a case-by-case basis. Authors can request a waiver or discount during the submission process. For further details, contact with the Office of Molecular and Cellular Therapies directly.

Author Guidelines

Guidelines for Authors Submitting Journal Paper
Action points before submission of final manuscript. Please use this list to ensure that  your manuscript is complete. In case of any queries, please get in touch with your contact
person at River Publishers.

Fees and funding
Article-processing charges. The journal of Molecular and Cellular Therapies is an open access journal with costs. The article-processing charge of MCT is $1000/ £770/€870 for
each article accepted for publication. The charges can be waived or discounted on a case-by-case basis. Authors can request a waiver or discount during the submission
process. For further details, contact with the Office of Molecular and Cellular Therapies directly.

Language editing services
All authors have to ensure the English language of submitted manuscript to Molecular and Cellular Therapies, with sufficient quality to be understood. If you need help with writing in
English you should consider, please contact with the Office of Molecular and Cellular Therapies directly.

Copyright on any open access article in Molecular and Cellular Therapies published by the Institute is retained by the author(s). Authors can grant any third party the right to use
the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. Please contact the Office of Molecular and Cellular Therapies for more information specifically regarding permissions if there are questions.

Preparing your manuscript
Molecular and Cellular Therapies publishes the following article types:

1. Research Article Preparing: Please refer the publication style of Clinical and Translational Medicine (clintransmed.springeropen.com).
Title page: The title page should include the title, the full names, institutional addresses
and email addresses for all authors, and the full information of the corresponding author
Abstract: The abstract should be less than360 words, with minimized use of
abbreviations and without cite references. The abstract must include Background with
aims, Results with main findings, and Conclusions.
Keywords: Please provide 5-6 keywords representing the main content of the article.

Background: The Background section should explain the background to the study, its
aims, a summary of the existing literature and aims of designed study.

Methods: The methods should include design and setting of the study, participants,
materials, all processes, interventions and comparisons, as well as statistical analysis

Results: The Results should include the main findings of the study, statistical analysis,
and tables and figures.

Discussion: The Discussion should include the implications of the findings, highlight
outstanding points and limitations of the study, explain study protocols and methodology,
and future potentials and indications.

Conclusions: The Conclusion should include a clear summary of main findings,
emphasize the importance and relevance of the study to the application, and indicate
future potentials.

Abbreviations: All abbreviations used in the text they should be defined in the text at first
appearance, and a list of abbreviations should be provided.

Ethics: Ethics approval and consent should be clearly addressed in the text. Manuscripts
involving human participants, human data or human tissue must include a statement on
ethics approval and consent (even where the need for approval was waived) and the
name of the ethics committee that approved the study and the committee’s reference
number. Studies involving animals must include a statement on ethics approval.

Competing interests: All financial and non-financial competing interests must be
declared in this section.

Funding: All sources of funding for the research reported should be declared.
Authors' contributions: The section should clarify the individual contributions of each
author to the study.

Acknowledgements: The section should describe the appreciation for one who helps the
article, with the permission from all those mentioned in the Acknowledgements section.
Authors' information: The section requests each author provide the name, academic
title, affiliation, brief description of research projects, and outstanding contributions made.
Authors’ information will be listed in a separate Experts section of home page.

Image/Figures: All images must be submitted with a resolution of at least 500 dpi. Scanned
figures are not acceptable. Please note that our production department can request
changes to the artwork when the manuscript is first evaluated (immediately after
submission) AND with the first copyedit.

References Style:
 Article within a journal: Smith JJ. The world of science. Am J Sci. 1999;36:234-5.
 Article within a journal (no page numbers): Rohrmann S, Overvad K,
Bueno-de-Mesquita HB, Jakobsen MU, Egeberg R, Tjønneland A, et al. Meat
consumption and mortality - results from the European Prospective Investigation into
Cancer and Nutrition. BMC Medicine. 2013;11:63.
Article within a journal by DOI: Slifka MK, Whitton JL. Clinical implications of
dysregulated cytokine production. Dig J Mol Med. 2000;
Article within a journal supplement: Frumin AM, Nussbaum J, Esposito M. Functional
asplenia: demonstration of splenic activity by bone marrow scan. Blood
1979;59Suppl 1:26-32.
Book chapter, or an article within a book: Wyllie AH, Kerr JFR, Currie AR. Cell death:
the significance of apoptosis. In: Bourne GH, Danielli JF, Jeon KW, editors.
International review of cytology. London: Academic; 1980. p. 251-306.
OnlineFirst chapter in a series (without a volume designation but with a DOI): Saito Y,
Hyuga H. Rate equation approaches to amplification of enantiomeric excess and
chiral symmetry breaking. Top Curr Chem. 2007. doi:10.1007/128_2006_108.
Complete book, authored: Blenkinsopp A, Paxton P. Symptoms in the pharmacy: a
guide to the management of common illness. 3rd ed. Oxford: Blackwell Science;
Online document: Doe J. Title of subordinate document. In: The dictionary of
substances and their effects. Royal Society of Chemistry. 1999.
http://www.rsc.org/dose/title of subordinate document. Accessed 15 Jan 1999.
Online database: Healthwise Knowledgebase. US Pharmacopeia, Rockville. 1998.
http://www.healthwise.org. Accessed 21 Sept 1998.
Supplementary material/private homepage: Doe J. Title of supplementary material.
2000. http://www.privatehomepage.com. Accessed 22 Feb 2000.

2. Review/Mini-review
All review/mini-review articles are invited by the Editorial Board of Molecular and Cellular
Therapies and should meet the following criteria within the scope of Molecular and
Cellular Therapies:
  - Focus on the latest and front-line science and topics
  - Discuss certain areas and topics with multi-opinions and comments
   - Analyze the progress in specified areas
  - Present systemic figures and full picture of specified molecules or cells

Review article is expected to be less than 6000 words, 8 figures, and 100 references.

3. Editorial/Perspective/Commentaries
Editorials/Perspectives/Commentaries bring the most attention on important issues, topics,
and areas, promote the discussion either by the phrasing of new hypotheses, alternative
interpretations of existing work, or by the presentation of new proposals for tackling
existing problems. Commentaries should be short and narrowly focused on contemporary
interest. Editorials/Perspectives/Commentaries are mostly invited and should be no longer
than 1500 words, 1 figure, and 10 references.

4. Case Report/Short Communication
Case Report/Short Communication will publish original and interesting case reports or
short research data that contribute significantly to medical knowledge. Manuscripts should
present unusual side effects or adverse interactions, unusual presentations of a disease,
or new light on the possible pathogenesis of a disease. Case Report/Short
Communication should be no longer than 2000, 3 figures, and 30 references.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.